Danaher Corp. closed 34.49% below its 52-week high of $281.70, which the company achieved on August 1st.

The Business Research Company’s Scientific Instruments Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 ...

Tema Etfs LLC just threw nearly $1.6 million at Danaher, grabbing 6,869 shares during the fourth quarter. They weren’t ...

We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks that Jim ...

The growing demand for Foley catheters is driven by several important factors. Firstly, the rising global aging population is contributing to a highe ...

The global HIV diagnosis market, valued at US$2.96 billion in 2024, is forecasted to grow at a robust CAGR of 10.3%, reaching ...

DHR gains from strength across its businesses, acquired assets and shareholder-friendly policies. High long-term debt remains concerning.

Fresh off a $275 million fundraise—the largest in digital health so far this year—Innovaccer’s cofounder and CEO Abhinav ...

Siemens Fonds Invest GmbH sold 78.2% of its Danaher holdings, unloading 18,220 shares in Q4 alone. Meanwhile, institutional ...

Shares of Danaher Corp. slipped 5.54% to $186.81 Wednesday, on what proved to be an all-around poor trading session for the ...

With a trading volume of 2,974,010, the price of DHR is down by -1.03%, reaching $195.74. Current RSI values indicate that the stock is is currently neutral between overbought and oversold. Next ...

Danaher has a lower P/E than the aggregate P/E of 44.52 of the Life Sciences Tools & Services industry. Ideally, one might ...